IONTAS and IGEM Therapeutics Collaborate to Identify Novel IgE Antibodies for Cancer Targets
In All, PortfolioCambridge, UK, 04 April 2018: IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, announced today that it will collaborate with IGEM Therapeutics (IGEM), an immuno-oncology company developing novel immunoglobulin E (IgE) antibodies to treat cancer. The project will add…